Kestra targets $141M FY 2027 revenue and mid-70% gross margin in next few years as Q1 revenue reaches $31M (NASDAQ:KMTS)
· seekingalpha.com
Kestra Medical (KMTS) Q1 FY2027 earnings call: 60% revenue growth, raised FY27 guide to $141M and mid-70s margin target.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...